Discover how QIAGEN Ingenuity Pathway Analysis (IPA) and OmicSoft Studio empower researchers to uncover hidden synergies within their existing drug portfolios. Whether you're exploring new indications or repurposing known compounds, these tools provide a data-driven framework to accelerate discovery and reduce development costs.

Learn how to:

• Diagram their current pipeline of drugs, targets and indications using IPA’s network construction and overlay tools

• Introduce a new gene signature and assess its interaction with known targets and pathways

• Query curated real-world datasets from OmicSoft Lands to validate predicted interactions and uncover novel therapeutic opportunities

• Compare gene profiles against disease vs. normal datasets to identify candidates for indication expansion

Join us to see how integrating deeply curated ‘omics data with predictive analytics can transform your drug development strategy.